tiprankstipranks
Trending News
More News >
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market

AXIM Biotechnologies (AXIM) Income Statement

Compare
151 Followers

AXIM Biotechnologies Income Statement

Last quarter (Q4 2024), AXIM Biotechnologies's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, AXIM Biotechnologies's net income was $-416.58K. See AXIM Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 70.46K$ 39.52K$ 8.88K$ 60.46K$ 0.00
Gross Profit
$ -369.27K$ 39.52K$ -417.25K$ 60.46K$ -16.00K
Operating Expenses
$ 1.39M$ 2.79M$ 4.66M$ 7.79M$ 4.83M
Depreciation and Amortization
$ 432.39K$ 427.02K$ 426.13K$ 2.12M$ 16.00K
EBITDA
$ -2.44M$ -6.43M$ -3.94M$ -13.17M$ -4.93M
Operating Income
$ -1.76M$ -2.75M$ -4.65M$ -7.99M$ -4.95M
Other Income/Expenses
$ -1.75M$ -5.31M$ -1.59M$ -2.05M$ -1.34M
Pretax Income
$ -3.51M$ -8.06M$ -6.24M$ -16.02M$ -6.29M
Net Income
$ -3.51M$ -8.06M$ -5.96M$ -16.52M$ -6.73M
Per Share Metrics
Basic EPS
$ -0.01$ -0.04$ -0.04$ -0.13$ -0.06
Diluted EPS
$ -0.01$ -0.04$ -0.04$ -0.13$ -0.06
Weighted Average Shares Outstanding
318.90M 227.69M 165.47M 131.54M 110.39M
Weighted Average Shares Outstanding (Diluted)
318.90M 227.69M 165.47M 131.54M 110.39M
Currency in USD

AXIM Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis